Literature DB >> 2229143

Prognostic grouping: the next step in tumor classification.

P Hermanek1, R V Hutter, L H Sobin.   

Abstract

At present, staging of malignant tumors is based on the anatomical extent of disease defined by the T(umor) N(odes) M(etastasis) classification. The main objective of further efforts in classifying tumors is to identify additional independent prognostic factors and to create mathematical models that may predict disease progression by prognostic grouping. This article summarizes problems, methods and the design of coordinated studies on prognostic grouping.

Entities:  

Mesh:

Year:  1990        PMID: 2229143     DOI: 10.1007/bf01613004

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  5 in total

1.  Clinical-pathologic staging of large-bowel cancer. A report of the ASCRS Committee.

Authors:  L P Fielding
Journal:  Dis Colon Rectum       Date:  1988-03       Impact factor: 4.585

2.  Prognostic factors in rectal carcinoma. A contribution to the further development of tumor classification.

Authors:  P Hermanek; I Guggenmoos-Holzmann; F P Gall
Journal:  Dis Colon Rectum       Date:  1989-07       Impact factor: 4.585

3.  A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods.

Authors:  C M Balch; T M Murad; S J Soong; A L Ingalls; N B Halpern; W A Maddox
Journal:  Ann Surg       Date:  1978-12       Impact factor: 12.969

4.  Predictors of survival after curative resection of carcinoma of the colon and rectum.

Authors:  M R Griffin; E J Bergstralh; R J Coffey; R W Beart; L J Melton
Journal:  Cancer       Date:  1987-11-01       Impact factor: 6.860

5.  Prediction of outcome after curative resection for large bowel cancer.

Authors:  L P Fielding; R K Phillips; J S Fry; R Hittinger
Journal:  Lancet       Date:  1986-10-18       Impact factor: 79.321

  5 in total
  7 in total

Review 1.  The impact of surgery on the multidisciplinary treatment of bronchogenic small cell carcinoma (updated review including ongoing studies).

Authors:  W Theuer; O Selawry; K Karrer
Journal:  Med Oncol Tumor Pharmacother       Date:  1992

2.  Investigational Strategies for Detection and Intervention in Early-Stage Pancreatic Cancer. April 24-27, Annapolis, Maryland. Abstracts.

Authors: 
Journal:  Int J Pancreatol       Date:  1994 Oct-Dec

3.  Staging of cancer revisited.

Authors:  M K Gospodarowicz; B O'Sullivan; H J Berkel; D J Beatty
Journal:  CMAJ       Date:  1994-03-01       Impact factor: 8.262

4.  [Prognostic factors in curative resection of stomach carcinoma. A uni- and multivariate analysis].

Authors:  J Gardovskis; O Horstmann; C Ohmann; P R Verreet; Q Yang; R Wlasak; N Bösing; F Borchard; H D Röher
Journal:  Langenbecks Arch Chir       Date:  1995

Review 5.  News of TNM and its use for classification of gastric cancer.

Authors:  P Hermanek; C Wittekind
Journal:  World J Surg       Date:  1995 Jul-Aug       Impact factor: 3.352

6.  Prognostic factors and survival in a heterogeneous sample of cancer patients.

Authors:  G I Ringdal; K G Götestam; S Kaasa; S Kvinnsland; K Ringdal
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

7.  Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate.

Authors:  Robert T Dess; Krithika Suresh; Michael J Zelefsky; Stephen J Freedland; Brandon A Mahal; Matthew R Cooperberg; Brian J Davis; Eric M Horwitz; Martha K Terris; Christopher L Amling; William J Aronson; Christopher J Kane; William C Jackson; Jason W D Hearn; Curtiland Deville; Theodore L DeWeese; Stephen Greco; Todd R McNutt; Daniel Y Song; Yilun Sun; Rohit Mehra; Samuel D Kaffenberger; Todd M Morgan; Paul L Nguyen; Felix Y Feng; Vidit Sharma; Phuoc T Tran; Bradley J Stish; Thomas M Pisansky; Nicholas G Zaorsky; Fabio Ynoe Moraes; Alejandro Berlin; Antonio Finelli; Nicola Fossati; Giorgio Gandaglia; Alberto Briganti; Peter R Carroll; R Jeffrey Karnes; Michael W Kattan; Matthew J Schipper; Daniel E Spratt
Journal:  JAMA Oncol       Date:  2020-12-01       Impact factor: 31.777

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.